Bank of America downgraded Stellantis NV (NYSE: STLA) to Underperform from Neutral, cutting its price target to €5.50 from €7.50 and citing rising competition from Chinese electric vehicle makers.
"The turnaround path now looks steeper than the stock had been pricing," Bank of America said in its report, arguing that the recent rally got ahead of execution. The firm highlighted that Stellantis's recovery is not yet proven and faces structural headwinds.
The downgrade was driven by the accelerating expansion of Chinese EV brands in Europe, where they have doubled their market share to around 8 percent with sales surging approximately 100 percent year-over-year in the first quarter. This trend is putting direct pressure on Stellantis's core markets and sprawling brand portfolio, which includes Jeep, Ram, Peugeot, and Fiat. The bank's report noted margin deterioration in Europe and market share declines in South America.
The move puts a spotlight on Stellantis's strategy ahead of its Investor Day on May 21. The bull case rests on its global scale and a partnership with China's Leapmotor to produce EVs in Spain. However, the downgrade suggests Wall Street's patience is wearing thin, with the stock down 32 percent year-to-date.
Competitive Pressures Mount
Bank of America's analysis reflects a broader industry concern. Chinese automakers like BYD and SAIC are no longer just competing on price but are pushing into segments traditionally dominated by European manufacturers. The bank also lowered its rating on Renault to Neutral for similar reasons, while maintaining a Buy on Volkswagen.
Stellantis's recent performance shows signs of stress. Its adjusted operating margin in "Enlarged Europe" collapsed to 0.1 points from 2.1 points, while Asia Pacific revenue fell 11 percent. The company reported a €22.3 billion net loss for the 2025 fiscal year, tied to impairments and program cancellations.
The downgrade puts the stock at a critical juncture, testing support levels. Investors will now look to the upcoming Investor Day for a defense of the company's execution roadmap and a clear plan to combat the margin erosion from new competitors.
This article is for informational purposes only and does not constitute investment advice.
